Physician profile
Spencer Hamner
NPI 1598853715
$4,029.66
in general payments reported to CMS, 2019-2025
17 companies · $846 in 2025
The $846 reported for 2025 was more than what 88% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $491 · 2022: $753 · 2023: $1,090 · 2024: $849 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,990 · Education: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,990.24 |
| Education | $795.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $780.28 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $724.16 | 2021-2025 | Ilumya |
| Incyte Corporation | $693.95 | 2021-2025 | Opzelura |
| Janssen Biotech, INC. | $615.45 | 2021-2025 | Tremfya, Simponi, Remicade |
| Lilly USA, LLC | $252.69 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Ucb, INC. | $227.52 | 2022-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $200.98 | 2023-2025 | Dupixent |
| Amgen INC. | $142.43 | 2023-2024 | Otezla, Repatha, Amjevita |
| Novartis Pharmaceuticals Corporation | $111.68 | 2022-2024 | |
| Genzyme Corporation | $68.30 | 2022-2025 | |
| Pfizer INC. | $51.38 | 2023 | |
| Arcutis Biotherapeutics, INC. | $34.92 | 2023-2024 | Zoryve |
| Galderma Laboratories, L.P. | $34.67 | 2021-2025 | Nemluvio |
| Helsinn Therapeutics (U.S.), INC. | $32.20 | 2021-2022 | |
| Sandoz INC. | $26.50 | 2023 | Hyrimoz |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $19.99 | 2022 | |
| Organon LLC | $12.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Hamner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.